Actavia Life Sciences (Actavia Life Sciences) Total Assets : $0.03 Mil (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Actavia Life Sciences Total Assets?

Actavia Life Sciences's Total Assets for the quarter that ended in Dec. 2023 was $0.03 Mil.

During the past 12 months, Actavia Life Sciences's average Total Assets Growth Rate was -46.20% per year. During the past 3 years, the average Total Assets Growth Rate was 3.40% per year. During the past 5 years, the average Total Assets Growth Rate was -69.00% per year.

During the past 11 years, Actavia Life Sciences's highest 3-Year average Total Assets Growth Rate was 1613.40%. The lowest was -84.40%. And the median was -78.90%.

Total Assets is connected with ROA %. Actavia Life Sciences's annualized ROA % for the quarter that ended in Dec. 2023 was -970.49%. Total Assets is also linked to Revenue through Asset Turnover. Actavia Life Sciences's Asset Turnover for the quarter that ended in Dec. 2023 was 0.00.

Actavia Life Sciences Total Assets Historical Data

The historical data trend for Actavia Life Sciences's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actavia Life Sciences Total Assets Chart

Actavia Life Sciences Annual Data

Trend

Jun14

Jun15

Jun16

Mar17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Total Assets

Get a 7-Day Free Trial

4.95

0.03

0.05

0.09

0.10

Actavia Life Sciences Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Assets	Get a 7-Day Free Trial															0.06	0.05	0.04	0.10	0.03

Actavia Life Sciences Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Actavia Life Sciences's Total Assets for the fiscal year that ended in Sep. 2023 is calculated as

Total Assets	=	Total Equity (A: Sep. 2023 )	+	Total Liabilities (A: Sep. 2023 )
	=	-1.956	+	2.052
	=	0.10

Actavia Life Sciences's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2023 )	+	Total Liabilities (Q: Dec. 2023 )
	=	-2.104	+	2.13
	=	0.03

Actavia Life Sciences (OTCPK:RASP) Total Assets Explanation

Total Assets is connected with ROA %.

Actavia Life Sciences's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %	=	Net Income (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	-0.592	/	( (0.096	+	0.026)	/ 2 )
	=	-0.592	/	0.061
	=	-970.49 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Actavia Life Sciences's Asset Turnover for the quarter that ended in Dec. 2023 is

	Asset Turnover
=	Revenue (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
=	0	/	( (0.096	+	0.026)	/ 2 )
=	0	/	0.061
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Actavia Life Sciences Total Assets Related Terms

Thank you for viewing the detailed overview of Actavia Life Sciences's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Actavia Life Sciences (Actavia Life Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actavia Life Sciences Inc (OTCPK:RASP) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

420 Lexington Avenue, Suite 2525, New York, NY, USA, 10170

Website

https://www.rasna.com

Rasna Therapeutics Inc is a clinical-stage biotechnology company focused on targeted drugs to treat diseases in oncology and immunology, mainly focusing on the treatment of leukemia. Its primary indication is Acute Myeloid Leukemia (AML), which may be fatal within weeks to months, has about a 5-year survival rate of only about 25% and very poor prospects for the long-term survival of patients.

Actavia Life Sciences (Actavia Life Sciences) Headlines

No Headlines